Irene Check
Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hemoglobins, Abnormal | 1 | 2008 | 5 | 0.370 |
Why?
| Hemoglobin A | 1 | 2008 | 9 | 0.370 |
Why?
| Pregnancy Complications, Hematologic | 1 | 2008 | 17 | 0.370 |
Why?
| Blood Specimen Collection | 1 | 2008 | 35 | 0.360 |
Why?
| Erythrocyte Transfusion | 1 | 2008 | 56 | 0.350 |
Why?
| Paraproteinemias | 4 | 1998 | 12 | 0.330 |
Why?
| Anemia, Sickle Cell | 1 | 2008 | 132 | 0.320 |
Why?
| Sarcoidosis | 6 | 1987 | 91 | 0.320 |
Why?
| Polyethylene Glycols | 5 | 1992 | 393 | 0.310 |
Why?
| Immunoglobulin G | 9 | 1991 | 483 | 0.300 |
Why?
| Meniere Disease | 1 | 2002 | 6 | 0.250 |
Why?
| CD4 Lymphocyte Count | 1 | 2002 | 75 | 0.250 |
Why?
| Poloxalene | 3 | 1990 | 8 | 0.240 |
Why?
| Amniocentesis | 1 | 2001 | 33 | 0.230 |
Why?
| Antibodies, Antinuclear | 2 | 1999 | 88 | 0.230 |
Why?
| Amniotic Fluid | 1 | 2001 | 37 | 0.230 |
Why?
| alpha-Fetoproteins | 1 | 2001 | 45 | 0.220 |
Why?
| Hypersensitivity, Delayed | 2 | 1999 | 27 | 0.220 |
Why?
| T-Lymphocyte Subsets | 1 | 2002 | 301 | 0.210 |
Why?
| Chickenpox Vaccine | 1 | 1999 | 8 | 0.200 |
Why?
| Ultrasonography, Prenatal | 1 | 2001 | 179 | 0.200 |
Why?
| Chickenpox | 1 | 1999 | 42 | 0.200 |
Why?
| Lymphocytes | 9 | 1987 | 479 | 0.200 |
Why?
| Vitamin A | 1 | 1999 | 33 | 0.190 |
Why?
| Tuberculosis, Pulmonary | 1 | 1999 | 29 | 0.190 |
Why?
| Nutrition Assessment | 1 | 1999 | 23 | 0.190 |
Why?
| Veterans | 1 | 1999 | 55 | 0.190 |
Why?
| Leukocyte Count | 7 | 1987 | 225 | 0.190 |
Why?
| Immunologic Tests | 1 | 1998 | 4 | 0.190 |
Why?
| Environmental Pollutants | 1 | 1999 | 47 | 0.190 |
Why?
| Immunoglobulins | 5 | 1999 | 156 | 0.180 |
Why?
| Autoantibodies | 3 | 1999 | 261 | 0.180 |
Why?
| Peptidyl-Dipeptidase A | 3 | 1986 | 28 | 0.180 |
Why?
| Adjuvants, Immunologic | 4 | 1992 | 166 | 0.170 |
Why?
| Health Personnel | 1 | 1999 | 185 | 0.170 |
Why?
| Autoimmune Diseases | 2 | 1998 | 236 | 0.160 |
Why?
| Gallium Radioisotopes | 5 | 1987 | 29 | 0.160 |
Why?
| Lung Diseases | 4 | 1986 | 271 | 0.150 |
Why?
| Ethylenediamines | 2 | 1992 | 14 | 0.150 |
Why?
| Multiple Myeloma | 3 | 1989 | 288 | 0.150 |
Why?
| Lung | 5 | 1987 | 1079 | 0.130 |
Why?
| Adrenocorticotropic Hormone | 2 | 1992 | 142 | 0.120 |
Why?
| Bronchi | 4 | 1987 | 235 | 0.120 |
Why?
| Pituitary Gland, Anterior | 1 | 1992 | 23 | 0.120 |
Why?
| Ionophores | 1 | 1992 | 14 | 0.120 |
Why?
| Humans | 52 | 2008 | 84199 | 0.120 |
Why?
| Nephrotic Syndrome | 2 | 1989 | 32 | 0.120 |
Why?
| Female | 32 | 2008 | 45032 | 0.110 |
Why?
| Blood Viscosity | 2 | 1990 | 18 | 0.110 |
Why?
| Agranulocytosis | 3 | 1986 | 23 | 0.110 |
Why?
| Plasmacytoma | 1 | 1990 | 36 | 0.110 |
Why?
| Blood Proteins | 4 | 1989 | 160 | 0.100 |
Why?
| Cyclosporins | 1 | 1990 | 66 | 0.100 |
Why?
| Practice Guidelines as Topic | 1 | 1998 | 1088 | 0.100 |
Why?
| T-Lymphocytes | 5 | 1999 | 1304 | 0.100 |
Why?
| Neutropenia | 4 | 1986 | 223 | 0.100 |
Why?
| Adult | 20 | 2008 | 26137 | 0.100 |
Why?
| Intracranial Arteriovenous Malformations | 2 | 2007 | 150 | 0.100 |
Why?
| Fibrin | 1 | 1990 | 83 | 0.100 |
Why?
| Solubility | 3 | 1999 | 213 | 0.100 |
Why?
| Agammaglobulinemia | 1 | 1989 | 21 | 0.100 |
Why?
| Complement C3 Nephritic Factor | 1 | 1989 | 3 | 0.100 |
Why?
| Histocompatibility Antigens Class II | 1 | 1990 | 174 | 0.100 |
Why?
| Glomerulonephritis, Membranoproliferative | 1 | 1989 | 13 | 0.100 |
Why?
| Complement Inactivator Proteins | 1 | 1989 | 28 | 0.100 |
Why?
| Pulmonary Alveoli | 2 | 1987 | 84 | 0.100 |
Why?
| Hemoglobin, Sickle | 1 | 2008 | 17 | 0.090 |
Why?
| Male | 28 | 2002 | 42140 | 0.090 |
Why?
| Oligoclonal Bands | 1 | 2007 | 7 | 0.090 |
Why?
| Pulmonary Fibrosis | 2 | 1987 | 119 | 0.090 |
Why?
| Coronary Artery Bypass | 1 | 1990 | 216 | 0.090 |
Why?
| Pregnancy | 2 | 2008 | 2849 | 0.090 |
Why?
| Therapeutic Irrigation | 6 | 1987 | 66 | 0.090 |
Why?
| Immunoglobulin Isotypes | 3 | 1991 | 33 | 0.080 |
Why?
| Macrophages | 1 | 1990 | 563 | 0.080 |
Why?
| Paraproteins | 2 | 1983 | 3 | 0.080 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 1984 | 160 | 0.080 |
Why?
| Child, Preschool | 5 | 1999 | 3788 | 0.080 |
Why?
| T-Lymphocytes, Regulatory | 3 | 1984 | 283 | 0.070 |
Why?
| Hemangioma, Cavernous, Central Nervous System | 1 | 2007 | 227 | 0.070 |
Why?
| Steroids | 1 | 1985 | 176 | 0.070 |
Why?
| Prognosis | 7 | 1999 | 3729 | 0.070 |
Why?
| Pyoderma | 1 | 1983 | 3 | 0.070 |
Why?
| Polychondritis, Relapsing | 1 | 1983 | 5 | 0.070 |
Why?
| Corneal Ulcer | 1 | 1983 | 14 | 0.070 |
Why?
| Brain Neoplasms | 2 | 2007 | 807 | 0.070 |
Why?
| CD4-CD8 Ratio | 1 | 2002 | 22 | 0.060 |
Why?
| Integrin alpha4 | 1 | 2002 | 11 | 0.060 |
Why?
| Transferrin | 3 | 1989 | 20 | 0.060 |
Why?
| Receptors, Interleukin-2 | 1 | 2002 | 74 | 0.060 |
Why?
| Anemia, Hemolytic, Autoimmune | 1 | 1982 | 15 | 0.060 |
Why?
| Middle Aged | 18 | 2002 | 25702 | 0.060 |
Why?
| Diagnosis, Computer-Assisted | 1 | 1985 | 327 | 0.060 |
Why?
| Electrophoresis, Agar Gel | 4 | 1986 | 58 | 0.060 |
Why?
| Cytotoxicity, Immunologic | 5 | 1990 | 272 | 0.060 |
Why?
| Liver Transplantation | 1 | 1990 | 1251 | 0.060 |
Why?
| Carcinoma, Bronchogenic | 1 | 1981 | 30 | 0.060 |
Why?
| Immunologic Techniques | 1 | 1981 | 30 | 0.060 |
Why?
| Adolescent | 6 | 2001 | 9210 | 0.050 |
Why?
| Lymphocyte Activation | 3 | 1984 | 813 | 0.050 |
Why?
| Immunophenotyping | 1 | 2001 | 220 | 0.050 |
Why?
| Immunoglobulin lambda-Chains | 3 | 2001 | 42 | 0.050 |
Why?
| Lymphoma, B-Cell | 1 | 2001 | 98 | 0.050 |
Why?
| Costs and Cost Analysis | 1 | 2001 | 153 | 0.050 |
Why?
| Acute Disease | 1 | 2002 | 869 | 0.050 |
Why?
| Immunohistochemistry | 3 | 2007 | 1830 | 0.050 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 2001 | 127 | 0.050 |
Why?
| Immunoglobulin kappa-Chains | 3 | 2001 | 96 | 0.050 |
Why?
| Prospective Studies | 2 | 1999 | 4122 | 0.050 |
Why?
| Proteins | 1 | 1986 | 783 | 0.050 |
Why?
| Genital Neoplasms, Female | 1 | 1980 | 89 | 0.050 |
Why?
| Asia, Southeastern | 1 | 1999 | 15 | 0.050 |
Why?
| Microsomes | 1 | 1999 | 37 | 0.050 |
Why?
| Latex | 1 | 1979 | 3 | 0.050 |
Why?
| Opsonin Proteins | 1 | 1979 | 8 | 0.050 |
Why?
| Rheumatoid Factor | 1 | 1999 | 26 | 0.050 |
Why?
| Herpesvirus 3, Human | 1 | 1999 | 38 | 0.050 |
Why?
| Gelatin | 1 | 1979 | 25 | 0.050 |
Why?
| Histoplasma | 1 | 1979 | 12 | 0.050 |
Why?
| Histoplasmosis | 1 | 1979 | 23 | 0.050 |
Why?
| Flow Cytometry | 1 | 2001 | 728 | 0.050 |
Why?
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1980 | 111 | 0.050 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2002 | 518 | 0.050 |
Why?
| Eye Diseases | 1 | 1979 | 55 | 0.050 |
Why?
| Microspheres | 1 | 1979 | 168 | 0.050 |
Why?
| Disease Transmission, Infectious | 1 | 1999 | 64 | 0.050 |
Why?
| Radionuclide Imaging | 4 | 1987 | 236 | 0.050 |
Why?
| Killer Cells, Natural | 3 | 1986 | 306 | 0.040 |
Why?
| Carcinoma, Small Cell | 1 | 1978 | 140 | 0.040 |
Why?
| Blood Protein Electrophoresis | 3 | 1986 | 17 | 0.040 |
Why?
| Muscle, Smooth | 1 | 1999 | 372 | 0.040 |
Why?
| Thyroid Gland | 1 | 1999 | 289 | 0.040 |
Why?
| Lung Neoplasms | 2 | 1981 | 2135 | 0.040 |
Why?
| Lymph Nodes | 2 | 1990 | 536 | 0.040 |
Why?
| Antigens, CD | 1 | 1999 | 485 | 0.040 |
Why?
| Child | 6 | 1999 | 6847 | 0.040 |
Why?
| Carcinoma | 1 | 1980 | 443 | 0.040 |
Why?
| Lymphocytosis | 2 | 1986 | 8 | 0.040 |
Why?
| Longitudinal Studies | 1 | 1999 | 991 | 0.040 |
Why?
| Mitochondria | 1 | 1999 | 536 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 1998 | 1774 | 0.040 |
Why?
| Aged | 10 | 2001 | 18611 | 0.030 |
Why?
| Antibodies, Monoclonal | 3 | 1999 | 1528 | 0.030 |
Why?
| Double-Blind Method | 1 | 1999 | 1912 | 0.030 |
Why?
| Leukemia, Lymphoid | 3 | 1982 | 71 | 0.030 |
Why?
| Mice | 7 | 1992 | 11210 | 0.030 |
Why?
| Animals | 11 | 2007 | 27167 | 0.030 |
Why?
| Iron | 3 | 1989 | 171 | 0.030 |
Why?
| Head and Neck Neoplasms | 1 | 1980 | 1010 | 0.030 |
Why?
| Severity of Illness Index | 1 | 1999 | 1784 | 0.030 |
Why?
| Type C Phospholipases | 1 | 1992 | 35 | 0.030 |
Why?
| Breast Neoplasms | 2 | 1991 | 2788 | 0.030 |
Why?
| Kinetics | 2 | 1992 | 1624 | 0.030 |
Why?
| Infant | 1 | 1999 | 3136 | 0.030 |
Why?
| Polymers | 2 | 1991 | 235 | 0.030 |
Why?
| Myeloma Proteins | 2 | 1989 | 33 | 0.030 |
Why?
| Bacterial Capsules | 1 | 1991 | 28 | 0.030 |
Why?
| Plasmodium | 1 | 1991 | 11 | 0.030 |
Why?
| Erythrocytes | 1 | 1992 | 269 | 0.030 |
Why?
| Antigens, Protozoan | 1 | 1991 | 24 | 0.030 |
Why?
| Antibodies, Protozoan | 1 | 1991 | 36 | 0.030 |
Why?
| Streptococcus pneumoniae | 1 | 1991 | 62 | 0.030 |
Why?
| Polysaccharides, Bacterial | 1 | 1991 | 38 | 0.030 |
Why?
| Antibodies, Bacterial | 1 | 1991 | 96 | 0.030 |
Why?
| Receptors, Progesterone | 1 | 1991 | 166 | 0.030 |
Why?
| Potassium | 1 | 1992 | 308 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 2 | 1982 | 190 | 0.030 |
Why?
| Temperature | 1 | 1992 | 424 | 0.030 |
Why?
| Protozoan Proteins | 1 | 1991 | 80 | 0.030 |
Why?
| Receptors, Transferrin | 1 | 1990 | 15 | 0.030 |
Why?
| Blood Sedimentation | 1 | 1990 | 16 | 0.030 |
Why?
| Hematocrit | 1 | 1990 | 78 | 0.030 |
Why?
| Macrophage Activation | 1 | 1990 | 39 | 0.030 |
Why?
| Biopolymers | 1 | 1990 | 25 | 0.030 |
Why?
| Fibrinogen | 1 | 1990 | 59 | 0.030 |
Why?
| Superoxides | 1 | 1990 | 83 | 0.030 |
Why?
| Leukemia, Myelomonocytic, Acute | 1 | 1989 | 4 | 0.030 |
Why?
| Blood Bactericidal Activity | 1 | 1989 | 6 | 0.030 |
Why?
| Molecular Weight | 1 | 1990 | 372 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 1991 | 278 | 0.030 |
Why?
| Prednisone | 1 | 1990 | 264 | 0.020 |
Why?
| Hematopoiesis | 1 | 1990 | 159 | 0.020 |
Why?
| Dysgammaglobulinemia | 1 | 1989 | 4 | 0.020 |
Why?
| Mice, Inbred C3H | 1 | 1990 | 396 | 0.020 |
Why?
| IgG Deficiency | 1 | 1989 | 2 | 0.020 |
Why?
| Antigen-Presenting Cells | 1 | 1990 | 152 | 0.020 |
Why?
| Immunoglobulin Constant Regions | 1 | 1989 | 22 | 0.020 |
Why?
| Thymus Gland | 1 | 1990 | 225 | 0.020 |
Why?
| Rosette Formation | 3 | 1984 | 35 | 0.020 |
Why?
| B-Lymphocytes | 2 | 2007 | 795 | 0.020 |
Why?
| Receptors, Fc | 1 | 1989 | 34 | 0.020 |
Why?
| Spleen | 1 | 1990 | 512 | 0.020 |
Why?
| Microbial Sensitivity Tests | 1 | 1989 | 218 | 0.020 |
Why?
| Immunoassay | 1 | 1989 | 94 | 0.020 |
Why?
| Immunoglobulin Variable Region | 1 | 1989 | 118 | 0.020 |
Why?
| Kidney Glomerulus | 1 | 1989 | 118 | 0.020 |
Why?
| Genes, Immunoglobulin | 1 | 1989 | 115 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1989 | 411 | 0.020 |
Why?
| Ischemic Attack, Transient | 1 | 1989 | 177 | 0.020 |
Why?
| Antibody-Dependent Cell Cytotoxicity | 2 | 1986 | 25 | 0.020 |
Why?
| Mice, Nude | 1 | 1990 | 787 | 0.020 |
Why?
| Blood Cell Count | 2 | 1986 | 80 | 0.020 |
Why?
| Mice, Inbred ICR | 3 | 1992 | 70 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 1992 | 2104 | 0.020 |
Why?
| Cell Line | 1 | 1992 | 2620 | 0.020 |
Why?
| Plasma Cells | 1 | 2007 | 105 | 0.020 |
Why?
| Clinical Enzyme Tests | 1 | 1986 | 8 | 0.020 |
Why?
| Immunoglobulin M | 2 | 1986 | 172 | 0.020 |
Why?
| Densitometry | 1 | 1986 | 29 | 0.020 |
Why?
| Electrophoresis | 1 | 1986 | 60 | 0.020 |
Why?
| Anemia, Hypochromic | 1 | 1985 | 5 | 0.020 |
Why?
| Skin Tests | 3 | 1982 | 47 | 0.020 |
Why?
| Apoproteins | 1 | 1985 | 22 | 0.020 |
Why?
| Microcomputers | 1 | 1985 | 29 | 0.020 |
Why?
| Recurrence | 1 | 1989 | 1200 | 0.020 |
Why?
| Clone Cells | 1 | 1986 | 305 | 0.020 |
Why?
| Respiratory Function Tests | 1 | 1986 | 148 | 0.020 |
Why?
| United States | 1 | 1998 | 6396 | 0.020 |
Why?
| Hyperplasia | 2 | 1990 | 157 | 0.020 |
Why?
| Vital Capacity | 1 | 1985 | 62 | 0.020 |
Why?
| Anemia | 1 | 1986 | 130 | 0.020 |
Why?
| Image Processing, Computer-Assisted | 1 | 1991 | 1182 | 0.020 |
Why?
| Lymphocyte Culture Test, Mixed | 2 | 1984 | 97 | 0.020 |
Why?
| Neoplasm Staging | 2 | 1981 | 1935 | 0.020 |
Why?
| Cerebrospinal Fluid Proteins | 1 | 1984 | 9 | 0.020 |
Why?
| Cell Count | 2 | 1984 | 213 | 0.020 |
Why?
| Bayes Theorem | 1 | 1985 | 337 | 0.020 |
Why?
| Diagnosis, Differential | 2 | 1985 | 1611 | 0.020 |
Why?
| Meningism | 1 | 1983 | 1 | 0.020 |
Why?
| Methods | 2 | 1984 | 184 | 0.020 |
Why?
| Albumins | 1 | 1984 | 120 | 0.020 |
Why?
| Nervous System Diseases | 1 | 1984 | 148 | 0.020 |
Why?
| Leukocytes | 2 | 1982 | 199 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 1984 | 259 | 0.020 |
Why?
| Granuloma | 1 | 1982 | 52 | 0.020 |
Why?
| Freund's Adjuvant | 2 | 1992 | 30 | 0.010 |
Why?
| Karyotyping | 1 | 1982 | 265 | 0.010 |
Why?
| Interferons | 1 | 1982 | 130 | 0.010 |
Why?
| Inflammation | 1 | 2007 | 845 | 0.010 |
Why?
| Antigens, CD20 | 1 | 2001 | 36 | 0.010 |
Why?
| Antigens, CD19 | 1 | 2001 | 35 | 0.010 |
Why?
| Flagella | 2 | 1991 | 16 | 0.010 |
Why?
| Sclerosis | 1 | 2001 | 30 | 0.010 |
Why?
| Immunization | 2 | 1992 | 165 | 0.010 |
Why?
| Antigens, Surface | 3 | 1986 | 134 | 0.010 |
Why?
| Serum Albumin, Bovine | 2 | 1991 | 59 | 0.010 |
Why?
| Antigens | 1 | 1982 | 270 | 0.010 |
Why?
| Antigens, Fungal | 1 | 1980 | 10 | 0.010 |
Why?
| Chromosomes, Human, 13-15 | 1 | 1980 | 33 | 0.010 |
Why?
| Necrosis | 1 | 2001 | 207 | 0.010 |
Why?
| Mitosis | 1 | 2001 | 148 | 0.010 |
Why?
| Centrifugation, Density Gradient | 1 | 1980 | 116 | 0.010 |
Why?
| Chromosome Aberrations | 1 | 1982 | 400 | 0.010 |
Why?
| Immunity, Cellular | 1 | 1980 | 191 | 0.010 |
Why?
| Blood Preservation | 1 | 1979 | 10 | 0.010 |
Why?
| Lymphoma | 1 | 1981 | 281 | 0.010 |
Why?
| Rabbits | 2 | 1992 | 729 | 0.010 |
Why?
| Liver | 2 | 1990 | 1260 | 0.010 |
Why?
| Agglutination Tests | 1 | 1979 | 12 | 0.010 |
Why?
| Antibodies, Fungal | 1 | 1979 | 8 | 0.010 |
Why?
| Brain | 2 | 2007 | 2165 | 0.010 |
Why?
| Rats, Inbred Lew | 1 | 1979 | 210 | 0.010 |
Why?
| Rats | 2 | 1992 | 4351 | 0.010 |
Why?
| Mice, Inbred BALB C | 2 | 1992 | 1078 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2007 | 1960 | 0.010 |
Why?
| Antibody Formation | 2 | 1992 | 214 | 0.010 |
Why?
| Phenotype | 4 | 1986 | 2320 | 0.010 |
Why?
| Kidney Transplantation | 1 | 1981 | 835 | 0.010 |
Why?
| Serum Albumin | 2 | 1986 | 140 | 0.010 |
Why?
| Apoptosis | 1 | 2001 | 1782 | 0.010 |
Why?
| Goats | 1 | 1992 | 20 | 0.010 |
Why?
| Guinea Pigs | 1 | 1992 | 179 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1992 | 341 | 0.010 |
Why?
| Charcoal | 1 | 1991 | 14 | 0.010 |
Why?
| Dextrans | 1 | 1991 | 88 | 0.010 |
Why?
| Biochemistry | 1 | 1991 | 28 | 0.010 |
Why?
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 1991 | 4 | 0.010 |
Why?
| Saponins | 1 | 1991 | 37 | 0.010 |
Why?
| Hypophysectomy | 1 | 1990 | 12 | 0.010 |
Why?
| Hematopoiesis, Extramedullary | 1 | 1990 | 11 | 0.010 |
Why?
| Corticosterone | 1 | 1990 | 34 | 0.010 |
Why?
| Adrenalectomy | 1 | 1990 | 65 | 0.010 |
Why?
| Pituitary-Adrenal System | 1 | 1990 | 61 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2001 | 6605 | 0.010 |
Why?
| Drug Carriers | 1 | 1991 | 150 | 0.010 |
Why?
| Electrodes | 1 | 1989 | 84 | 0.010 |
Why?
| Organ Size | 1 | 1990 | 383 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 1989 | 207 | 0.010 |
Why?
| Disease Susceptibility | 1 | 1989 | 186 | 0.010 |
Why?
| Bone Marrow | 1 | 1990 | 421 | 0.010 |
Why?
| Cerebrovascular Circulation | 1 | 1989 | 220 | 0.010 |
Why?
| Pseudomonas aeruginosa | 1 | 1989 | 204 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1986 | 154 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 1991 | 2082 | 0.000 |
Why?
| Nutrition Disorders | 1 | 1985 | 15 | 0.000 |
Why?
| Microscopy, Electron | 1 | 1986 | 534 | 0.000 |
Why?
| Interleukin-2 | 1 | 1986 | 287 | 0.000 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 305 | 0.000 |
Why?
| Neutrophils | 1 | 1987 | 292 | 0.000 |
Why?
| Immunoenzyme Techniques | 1 | 1985 | 332 | 0.000 |
Why?
| Cells, Cultured | 2 | 1982 | 2974 | 0.000 |
Why?
| gamma-Globulins | 1 | 1984 | 17 | 0.000 |
Why?
| Nephrosis, Lipoid | 1 | 1984 | 5 | 0.000 |
Why?
| Concanavalin A | 1 | 1984 | 67 | 0.000 |
Why?
| Radiography | 1 | 1987 | 877 | 0.000 |
Why?
| Prealbumin | 1 | 1984 | 23 | 0.000 |
Why?
| Reference Values | 1 | 1985 | 704 | 0.000 |
Why?
| Cytoplasmic Granules | 1 | 1984 | 95 | 0.000 |
Why?
| Liver Diseases | 1 | 1985 | 228 | 0.000 |
Why?
| Histiocytes | 1 | 1983 | 22 | 0.000 |
Why?
| Leukemia | 1 | 1985 | 302 | 0.000 |
Why?
| Microtubules | 1 | 1984 | 117 | 0.000 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1986 | 401 | 0.000 |
Why?
| Time Factors | 2 | 1986 | 5516 | 0.000 |
Why?
| Streptodornase and Streptokinase | 1 | 1982 | 1 | 0.000 |
Why?
| Candida | 1 | 1982 | 21 | 0.000 |
Why?
| Lymphopenia | 1 | 1982 | 31 | 0.000 |
Why?
| Immune Complex Diseases | 1 | 1982 | 18 | 0.000 |
Why?
| Neutralization Tests | 1 | 1982 | 86 | 0.000 |
Why?
| Immunity, Innate | 1 | 1986 | 433 | 0.000 |
Why?
| Antigen-Antibody Complex | 1 | 1982 | 97 | 0.000 |
Why?
| Multiple Sclerosis | 1 | 1984 | 253 | 0.000 |
Why?
| Statistics as Topic | 1 | 1983 | 243 | 0.000 |
Why?
| Spinal Cord | 1 | 1983 | 256 | 0.000 |
Why?
| Kidney Diseases | 1 | 1985 | 423 | 0.000 |
Why?
| Chromosomes, Human, 6-12 and X | 1 | 1980 | 24 | 0.000 |
Why?
| Monocytes | 1 | 1982 | 230 | 0.000 |
Why?
| Peroxidases | 1 | 1980 | 37 | 0.000 |
Why?
| Candida albicans | 1 | 1980 | 37 | 0.000 |
Why?
| Mice, Inbred DBA | 1 | 1980 | 197 | 0.000 |
Why?
| Culture Media | 1 | 1980 | 180 | 0.000 |
Why?
| Freezing | 1 | 1979 | 32 | 0.000 |
Why?
| Leukapheresis | 1 | 1979 | 22 | 0.000 |
Why?
| Receptors, Antigen, B-Cell | 1 | 1980 | 125 | 0.000 |
Why?
| DNA | 1 | 1986 | 1307 | 0.000 |
Why?
| Epitopes | 1 | 1980 | 308 | 0.000 |
Why?
| Translocation, Genetic | 1 | 1980 | 263 | 0.000 |
Why?
| Sheep | 1 | 1979 | 207 | 0.000 |
Why?
| Quality Control | 1 | 1979 | 127 | 0.000 |
Why?
| Cell Division | 1 | 1979 | 750 | 0.000 |
Why?
| Analysis of Variance | 1 | 1979 | 965 | 0.000 |
Why?
| Cell Survival | 1 | 1979 | 1016 | 0.000 |
Why?
| Postoperative Complications | 1 | 1981 | 2280 | 0.000 |
Why?
| Retrospective Studies | 1 | 1984 | 7798 | 0.000 |
Why?
|
|
Check's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|